Biomet Inc. Announces Third Quarter of Fiscal Year 2012 Financial Results

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today financial results for its third fiscal quarter ended February 29, 2012.

Net sales increased 5% (5% constant currency) worldwide to $709 million

- Large joint reconstructive sales increased 5% (5% constant currency) worldwide and increased 6% in the U.S.

- Sports medicine sales increased 22% (22% constant currency) worldwide, with 18% U.S. growth

- Extremity sales grew 18% (18% constant currency) worldwide, with a 21% increase in the U.S.

- Operating cash flow of $158 million

- Binding offer to acquire DePuy trauma business for $280 million